1 Product identity
Ingredient risk
1 ingredient to use with caution

500 mg Vitamin C

BrandEqualineVitamin Tablet or Pill 11 ingredients 1 caution DSLD #7574
Net contents: 100 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-04-26
2 Ingredients (11)
IngredientGroupSafety
Vitamin CVitamin CGenerally Safe
Ascorbic AcidVitamin CGenerally Safe
Corn StarchStarch
CelluloseCellulose
CrospovidoneCrospovidone
HypromelloseHypromellose
Croscarmellose SodiumCroscarmellose Sodium
Magnesium StearateMagnesium stearateUse with Caution
Hydroxypropyl CelluloseHypromellose
Stearic AcidStearic Acid
Silicon DioxideSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Qualified Health
5 Data source
DSLD ID7574
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-04-26
6 More from Equaline
View Equaline Safety Scorecard → 69 products
200 IU Vitamin E400 IU Vitamin E400 IU Vitamin E400 IU Vitamin E500 mg Vitamin CBalanced B-100 Complex
7 Cite this page
Vancouver
Pkhakadze G. 500 mg Vitamin C — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 29]. Available from: https://supplement.ge/products/500-mg-vitamin-c-7574/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG